...
【24h】

Bis-Arene Complexes [Re(eta(6)-arene)(2)](+) as Highly Stable Bioorganometallic Scaffolds

机译:Bis-Arene配合物[Re(eta(6)-arene)(2)](+)作为高度稳定的生物有机金属支架。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The synthesis of mono- and difunctionalized [Re(eta(6)-C6H5R)(eta(6)-C6H6-n R-n)](+) (n = 0, 1; R = COOH, Br) complexes starting from [Re(eta(6)-benzene)(2)](+) is described. The lithiation of [Re(eta(6)-benzene)(2)](+) with n-BuLi leads preferentially to the neutral, alkylated product [Re(eta(6)-C6H6)(eta(5)-C6H6-Bu)] but not to the expected deprotonation of the arene ring. Deprotonation/lithiation with LDA gave the mono- and the dilithiated products in situ. Their reactions with 1,1,2,2-tetra-bromoethane (TBE) or with CO2, respectively, gave [Re(eta(6)-C6H5Br)(eta(6)-C6H6)](+), [Re(eta(6)-C6H5Br)(2)](+), or [Re(eta(6-)-C6H5COOH)(eta(6)-C6H6)](+), [Re(eta(6)-C6H5COOH)(2)](+). These functionalized derivatives of [Re(eta(6)-benzene)(2)](+) represent novel precursors for the synthesis of bioconjugates to bioactive structures, comparable to [Co (Cp)(2)](+) or [Fe(Cp)(2)]. Different model compounds [Re(eta(6)-C6H5R)(eta(6)-C6H6-nRn)](+) (n = 0, 1; R= -SCH2Ph, -NHPh, -CONHCH2Ph, C6H5-COdpa) were synthesized via amide bond formation and nucleophilic aromatic substitution. These conjugates were fully characterized including X-ray structure analyses of most products. For all complexes, the NMR arene proton signals are strongly upfield-shifted as compared to those of the noncoordinated arenes. The electrochemical analyses show an irreversible, probably substituent-centered oxidation, which contrasts the cyclic voltammetry of the underivatized complexes where oxidation is fully reversible. The stability of the core and the reactivity of the substituents make these bis-arene complexes useful precursors in medicinal inorganic chemistry, comparable to cobaltocenium or ferrocene.
机译:从[Re开始]合成单官能和双官能的[Re(eta(6)-C6H5R)(eta(6)-C6H6-n Rn)](+)(n = 0,1; R = COOH,Br)络合物描述了(η(6)-苯)(2)](+)。 [Re(eta(6)-苯)(2)](+)与n-BuLi的锂化优先导致中性的烷基化产物[Re(eta(6)-C6H6)(eta(5)-C6H6- Bu)],但不影响芳烃环的预期质子化。用LDA进行去质子化/锂化,原位产生单和双锂化产物。他们分别与1,1,2,2-四溴乙烷(TBE)或与CO2的反应得到[Re(eta(6)-C6H5Br)(eta(6)-C6H6)](+),[Re( eta(6)-C6H5Br)(2)](+)或[Re(eta(6-)-C6H5COOH)(eta(6)-C6H6)](+),[Re(eta(6)-C6H5COOH) (2)](+)。这些[Re(eta(6)-苯)(2)](+)的官能化衍生物代表了可与[Co(Cp)(2)](+)或[Fe]相媲美的新型生物合成生物活性结构的前体。 (Cp)(2)]。不同的模型化合物[Re(eta(6)-C6H5R)(eta(6)-C6H6-nRn)](+)(n = 0,1; R = -SCH2Ph,-NHPh,-CONHCH2Ph,C6H5-COdpa)通过酰胺键形成和亲核芳族取代合成。这些结合物已得到充分表征,包括大多数产品的X射线结构分析。对于所有配合物,与非配位芳烃相比,NMR芳烃质子信号都向高场偏移。电化学分析显示不可逆的,可能是以取代基为中心的氧化,这与未完全氧化的可完全逆转的未衍生化配合物的循环伏安法形成了对比。核的稳定性和取代基的反应性使这些双芳烃配合物在药用无机化学中成为有用的前体,与钴to或二茂铁相当。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号